
|Articles|October 1, 2017
- Pharmaceutical Executive-10-01-2017
- Volume 37
- Issue 10
Pharmaceutical Executive, October 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Pharm Exec's Emerging Pharma Leaders 2017about 8 years ago
How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’about 8 years ago
Glimmers of Hope for Innovation Support in Europeabout 8 years ago
The Future of Real-World Studiesabout 8 years ago
Inspiring People, Inspiring Teamsabout 8 years ago
Country Report: ColombiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5





